Newly released Survival Data (from ASCO) with Oncosil devise and SOC demonstrates:-
(1) 64% of implanted patients were alive after 12 months.
(2) 50% of implanted patients (21/42) were alive after 16 months.
(3) Average overall survival of 16 months.
Compared to SOC (chemo only) of 9-11 months.
IMO this demonstrates efficacy and should be approved by the regulators.
Newly released Survival Data (from ASCO) with Oncosil devise and...
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.66M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $24.39K | 5.747M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 43 | 35921563 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 2967733 | 3 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 500000 | ||
| Last updated 14.11pm 31/05/2024 ? | |||||
| OSL (ASX) Chart |